AURORA, Colo., May 14 /PRNewswire/ -- MEDdevice Acquisition Co., LLC MDAC is proud to announce that it has engaged a highly experienced team with deep domain experience and proven success optimizing investments in the medical device market as board members and advisors.
Board members announced include:
Tony Dimun, CEO of Nascent Enterprises, LLC, formerly of Vital Signs Inc., and Bionx Implants Inc.
Larry Gold, PhD, Chairman and CEO of SomaLogic Inc., and formerly of NeXstar Pharma Inc., Gilead, and the University of Colorado.
Alan West a partner at Pittsburgh Life Sciences Greenhouse, and formerly of Michigan Tech Enterprise Corporation, Boston Scientific, and Vision Sciences Inc.
Advisors announced include:
Frank DeBernardis, CEO of Cascade medical and a partner in Nascent Enterprises, LLC, and formerly with Meadox Medical, and Medtronic.
Sean O'Connell, PhD, currently with the Hospital of Special Surgery and formerly with Novartis, and Robert Wood Johnson Medical School.
J. D. Friedland Managing Director of Epsilon Securities, and formerly with Rothschild Inc., Rinaldini & Co., and Lazard.
Christopher Hazlitt, Esq. of Faegre & Benson LLP.
For more information about MDAC or Epsilon Securities, please contact JD Friedland with Epsilon Securities, LLC directly at 212-242-8844 x.243 or through its website at http://www.epsilonsecurities.com .
About MEDdevice Acquisition Corporation
MEDdevice Acquisition Corporation ("MDAC") was formed by health care
industry professionals to acquire and optimize medical product companies
and assets. The focus of MDAC is to work with strategic partners to acquire
companies or divisions operating in complementary fields, establish
management efficiencies and superior market presence to provide
significantly enhanced market value in a minimal period of time. For more
information on MEDde
|SOURCE MEDdevice Acquisition Co., LLC|
Copyright©2008 PR Newswire.
All rights reserved